ASX 100

There are several pieces of credible evidence to support the case for a price bounce, which would be good news for fast-growing Patriot.

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse some of the market's hottest growth stocks.

Wilsons Advisory’s Melissa Benson and Shane Storey share their insights in the final part of the biotech mini-series.

We delve into the case for prioritising Value for a pathway beyond the current market conditions.

Aka the "lazy" way to build up your share portfolio.

From digging for unloved value to discovering the best founder-led companies, these investors have different views on how to generate alpha.

The most important month of the investing year is here - and the stakes are very high.

ResMed (ASX:RMD) reported its June quarter and full year results after the U.S. market closed on Friday morning. The company met consensus expectations for both...

Find out in this episode of Buy Hold Sell - featuring Henry Jennings from Marcus Today and James Gerrish from Market Matters.

ASX Reporting Season begins with Rio Tinto and ResMed surging. The RBA may pause rate hikes after lower inflation. Fed hints at rate cuts.

It's been a wild ride for ResMed over the past couple of years and while there might be further volatility, things are back on track

And why it's the points that you win that matter.

As BHP/Lundin lock in their South American prize, former geologist, James Cooper discusses the opportunity cost for junior mining investors

Metro says prices are surging. And now Flanagan’s Arrow has secured a big bauxite project; $9m Gateway pockets $14m from sale to Brightstar.

In this episode, Marcus Today's Henry Jennings and Market Matters' James Gerrish analyse a handful of stocks that could surprise in August.

Key themes and stocks to watch from the recently released Morgans 'Reporting Season Playbook'.

Yesterday, Rio Tinto (ASX: RIO) delivered its first half calendar year 2024 results (1HCY24). The results were largely in line, with an underlying net profit after tax...

With interest rate hikes starting to bite, just how resilient will Australia’s economy prove to be?

The brokers have quashed hopes of a positive reporting season, although it's not all doom and gloom when it comes to the year ahead.

We humans are a strange bunch and one psychological quirk has a lot to say about the state of the world.

Pushback against China is one of the few bipartisan policies among Republicans and Democrats; this could benefit ASX critical mineral stocks

Historical data suggests that companies that exceed earnings expectations tend to tick higher in the days and weeks that follow the result.

If Fortescue's share price is anything to go by, brokers didn't like its quarterly report. But is the share price dip a buying opportunity?

Companies that miss earnings expectations drop an average 6.3% on results day, and still down 8.4% four months later, says the Coppo Report.